The authors began recruiting patients into the TAILORx study approximately 10 years ago.
Now, in the field of breast cancer prognosis in 2015, have there been further valuable prognostic genes discovered which may warrant inclusion in an assay? In other words, should the 21-gene assay evolve into a more-than-21-gene assay to potentially give patients and clinicians more prognostic and/or treatment guidance?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.